This bill, known as the Penicillin Allergy Verification and Evaluation Act or PAVE Act, seeks to amend Title XVIII of the Social Security Act. Its primary purpose is to integrate penicillin allergy verification and evaluation into the Medicare program's initial preventive physical examination and annual wellness visits. This inclusion aims to address the widespread issue of mislabeled penicillin allergies, which often lead to suboptimal antibiotic choices and adverse patient outcomes. The bill defines "penicillin allergy verification and evaluation" to include several key steps. These steps involve identifying individuals with a reported allergy, assessing the consistency of their reaction history, educating patients on the negative impacts of an allergy label, and providing appropriate referrals to allergy or immunology specialists. By systematically evaluating these allergies, the legislation intends to improve patient care, promote antibiotic stewardship, and potentially reduce healthcare costs associated with alternative, often less effective, antibiotics. The provisions of this act are slated to take effect for examinations and visits furnished on or after January 1, 2027.